Walvax Biotechnology (300142)

Walvax Biotechnology (300142)

$ 10

Trading Risk Analysis

English Version

Date : 1 Jan 2021

Description

Walvax Biotechnology Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of vaccines, monoclonal antibodies and blood products. The Company?s main products include haemophilus influenza type b conjugate vaccines, freeze-dried group A,C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines and group A and C meningococcal polysaccharide vaccines, among others. The Company distributes its products mainly in domestic market.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner